MaxiVAX
OverviewSuggest Edit
MaxiVAX is a company that develops a personalized anti-cancer vaccination designed to build immunity against cancer. The company combines a vaccination process against the complete tumor cell with an immune system-boosting agent with its novel immunotherapy technology, thereby enabling cancer patients to get access to more treatment options.
| Type | Private | |
| Founded | 2013 | |
| HQ | Genève, CH | Map |
| Website | maxivax.ch |
Locations
Latest Updates
| Employees (est.) (Nov 2020) | 6 | |
| Cybersecurity rating | C | More |
MaxiVAX Office Locations
MaxiVAX has an office in Genève
Genève, CH (HQ)
Rue de l'Athénée 24
MaxiVAX Financials and Metrics
Summary Metrics
Founding Date | 2013 |
MaxiVAX total Funding | $8.1 m |
MaxiVAX latest funding size | $5.01 m |
Time since last funding | a year ago |
MaxiVAX's latest funding round in November 2019 was reported to be $5 m. In total, MaxiVAX has raised $8.1 m
MaxiVAX Cybersecurity Score
MaxiVAX Online and Social Media Presence
MaxiVAX's Trends
MaxiVAX Frequently Asked Questions
When was MaxiVAX founded?
MaxiVAX was founded in 2013.
How many employees does MaxiVAX have?
MaxiVAX has 6 employees.
Who are MaxiVAX competitors?
Competitors of MaxiVAX include FoRx Therapeutics, Werewolf Therapeutics and Verseau Therapeutics.
Where is MaxiVAX headquarters?
MaxiVAX headquarters is located at Rue de l'Athénée 24, Genève.
Where are MaxiVAX offices?
MaxiVAX has an office in Genève.
How many offices does MaxiVAX have?
MaxiVAX has 1 office.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies